Nantahala Capital Management, LLC Nektar Therapeutics Transaction History
Nantahala Capital Management, LLC
- $2.22 Billion
- Q1 2025
A detailed history of Nantahala Capital Management, LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 7,789,051 shares of NKTR stock, worth $5.06 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
7,789,051
Previous 7,810,000
0.27%
Holding current value
$5.06 Million
Previous $7.26 Million
27.08%
% of portfolio
0.24%
Previous 0.37%
Shares
4 transactions
Others Institutions Holding NKTR
# of Institutions
168Shares Held
123MCall Options Held
1.18MPut Options Held
64.6K-
Black Rock Inc. New York, NY15.2MShares$9.85 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$8 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.3MShares$4.75 Million0.01% of portfolio
-
Eventide Asset Management, LLC Boston, MA6.65MShares$4.32 Million0.1% of portfolio
-
Primecap Management CO Pasadena, CA5.35MShares$3.48 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $122M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...